Liu, Jingwen
Poon, Jiat-Ling
Bispham, Jeoffrey
Perez-Nieves, Magaly
Hughes, Allyson
Chapman, Katherine
Mitchell, Beth
Hood, Korey
Snoek, Frank
Fisher, Lawrence
Funding for this research was provided by:
Eli Lilly and Company (Eli Lilly and Company)
Article History
Received: 5 December 2022
Accepted: 24 April 2023
First Online: 9 May 2023
Declarations
:
: The study was reviewed and approved by the Western Institutional Review Board (WIRB® Protocol #20202,118). Participants completed study-specific informed consent forms prior to completing the survey.
: Not applicable; there are no individual data or images in this manuscript.
: Jiat-Ling Poon, Magaly Perez-Nieves, Beth Mitchell are employees and stockholders of Eli Lilly and Company. Katherine Chapman is employee of T1D Exchange. Jingwen Liu, Jeoffrey Bispham, and Allyson Hughes were employees of T1D Exchange at the time of this research.